MINC+ Benchtop Incubator for IVF Clinics by COOK Medical Launches in the US and Canada

The MINC+ Benchtop Incubator is now available to clinical embryologists and IVF clinics in the US and Canada.

The MINC+ is the next generation of the MINC® Mini Incubator, a benchtop incubator that has been a standard component in IVF clinics for more than 20 years.

“We listened to user feedback when designing the MINC+ and incorporated new and updated features that will make a big difference for embryologists,” said Olin Emmanuel, global director of Cook Medical’s Reproductive Health specialty, “so we’re very excited to introduce this technology to the IVF world.”

The MINC+ incubator also includes the DishTrace platform, which combines functionality through the incubator touchscreen and a PC software program to provide a wide range of dish-data management tools.

With the DishTrace platform, users can access and log information via the touchscreen, track culture dishes as they are checked in and out of the incubator, monitor up to 50 MINC+ incubators, and generate and view graphical histories and reports of MINC+ activity.

The MINC+ Benchtop incubator is part of a suite of assisted reproductive technology (ART) products offered by Cook Medical, including culture media and devices for ovum aspiration, intrauterine insemination, and embryo transfer and manipulation.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”